Ann Lab Med.  2014 Nov;34(6):469-470. 10.3343/alm.2014.34.6.469.

A Rare Case of Polycythemia Vera Following Acute Undifferentiated Leukemia Remission

• Youk HJ
• Cho CH
• Lee JH
• Choi CW
• Lim CS
• Yoon SY

• KMID: 2129574
• DOI: http://doi.org/10.3343/alm.2014.34.6.469

Abstract

No abstract available.

MeSH Terms

Acute Disease
Aged
Bone Marrow/metabolism/pathology
Female
Humans
Janus Kinase 2/genetics
Leukemia/*complications/therapy
Mutation, Missense
Polycythemia Vera/*diagnosis/etiology
Real-Time Polymerase Chain Reaction
Remission Induction
Janus Kinase 2

Reference

1. Passamonti F, Rumi E, Pietra D, Elena C, Boveri E, Arcaini L, et al. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia. 2010; 24:1574–1579. PMID: 20631743.

2. Antonioli E, Guglielmelli P, Poli G, Santini V, Bosi A, Vannucchi AM. Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance. Blood. 2007; 110:4620–4621. PMID: 18056850.

3. Tefferi A. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol. 2013; 88:507–516. PMID: 23695894.

4. Lee HJ, Daver N, Kantarjian HM, Verstovsek S, Ravandi F. The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia. Clin Cancer Res. 2013; 19:327–335. PMID: 23209034.

5. Gangat N, Strand J, Li CY, Wu W, Pardanani A, Tefferi A. Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation. Br J Haematol. 2007; 138:354–358. PMID: 17614822.

6. Jekarl DW, Han SB, Kim M, Lim J, Oh EJ, Kim Y, et al. JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia. Korean J Hematol. 2010; 45:46–50. PMID: 21120162.

7. Swaminathan S, Madkaikar M, Ghosh K, Vundinti BR, Kerketta L, Gupta M. Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation. Eur J Haematol. 2010; 84:180–182. PMID: 19824900.

8. Belotti A, Doni E, Elli E, Rossi V, Pioltelli P, Pogliani EM. Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report. Acta Haematol. 2011; 126:52–53. PMID: 21454967.

9. Portell CA, Sekeres MA, Rogers HJ, Tiu RV. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone. Br J Haematol. 2012; 157:266–267. PMID: 22150289.

10. Chabannon C, Bost M, Hollard D. A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission. Leukemia. 1994; 8:1243–1244. PMID: 8035619.